San Diego, CA, United States of America

Huynh-Hoa Bui

This inventor holds 28 USPTO granted patents and 42 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Gene Expression Modulation. Top assignees: Ionis Pharmaceuticals, Inc., Biogen Ma Inc., Astrazeneca Ab. Active years: 2017-2026.

USPTO Granted Patents = 28 

% Patents Active = 96.4

 

 

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Carlsbad, CA (US) (2023)
  • San Diego, CA (US) (2017 - 2024)

Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Expression
PKK Modulation
Tau Therapy
Growth Hormone Receptor
FUS Expression
Prion Reduction
Fatty Liver Disease
IRF4 Modulators
STMN2 Increase
PCSK9 Modulators
YAP1 Modulation
FXI Reduction
28 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Huynh-Hoa Bui in Biotechnology

Introduction

Huynh-Hoa Bui is a prominent inventor based in San Diego, California, known for his significant contributions to the field of biotechnology. With 23 patents to his name, his innovative work focuses on developing therapies that target specific molecular mechanisms involved in diseases, particularly those related to tau pathologies and cancer.

Latest Patents

Among his latest patents, one notable invention is related to compositions for modulating tau expression. This patent discloses antisense compounds and methods aimed at decreasing Tau mRNA and protein expression. The utility of these compounds and methods is particularly relevant in treating, preventing, or ameliorating tau-associated diseases, disorders, and conditions. Another significant patent involves modulators of IRF4 expression. This invention provides methods, compounds, and compositions that inhibit IRF4 expression, offering promising avenues for the treatment of cancers associated with this factor.

Career Highlights

Huynh-Hoa Bui has an extensive career in the biotechnology sector, having worked with well-respected organizations such as Ionis Pharmaceuticals, Inc. and Biogen MA Inc. His work at these companies has contributed to the advancement of therapeutic options in the fields of neurology and oncology.

Collaborations

Throughout his career, Bui has collaborated with esteemed colleagues, including Susan M. Freier and Eric E. Swayze. These collaborations have fostered the exchange of ideas and innovations, ultimately leading to breakthroughs in their respective research areas.

Conclusion

Huynh-Hoa Bui's dedication to innovation in biotechnology is evidenced by his numerous patents and collaborations. His work not only exemplifies the spirit of scientific inquiry but also holds the potential for significant advancements in the treatment of various diseases, underscoring his status as a crucial figure in modern biomedicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…